Standard BioTools Inc. (FRA:FLB)
Germany flag Germany · Delayed Price · Currency is EUR
1.290
+0.020 (1.57%)
At close: Dec 1, 2025

Standard BioTools Statistics

Total Valuation

FRA:FLB has a market cap or net worth of EUR 469.74 million. The enterprise value is 325.64 million.

Market Cap469.74M
Enterprise Value 325.64M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date Feb 6, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 384.57M
Shares Outstanding n/a
Shares Change (YoY) +35.61%
Shares Change (QoQ) +0.56%
Owned by Insiders (%) 2.03%
Owned by Institutions (%) 48.04%
Float 229.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.25
PB Ratio 1.38
P/TBV Ratio 1.38
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -2.98
EV / Sales 2.23
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -3.88

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.07.

Current Ratio 4.38
Quick Ratio 1.93
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF -0.28
Interest Coverage -239.68

Financial Efficiency

Return on equity (ROE) is -33.26% and return on invested capital (ROIC) is -17.66%.

Return on Equity (ROE) -33.26%
Return on Assets (ROA) -14.55%
Return on Invested Capital (ROIC) -17.66%
Return on Capital Employed (ROCE) -32.93%
Revenue Per Employee 177,288
Profits Per Employee -133,956
Employee Count818
Asset Turnover 0.28
Inventory Turnover 2.58

Taxes

Income Tax -1.40M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.65% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -27.65%
50-Day Moving Average 1.10
200-Day Moving Average 1.06
Relative Strength Index (RSI) 69.47
Average Volume (20 Days) 911

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 7.18

Income Statement

In the last 12 months, FRA:FLB had revenue of EUR 144.67 million and -109.31 million in losses. Loss per share was -0.29.

Revenue144.67M
Gross Profit 69.80M
Operating Income -121.14M
Pretax Income -127.41M
Net Income -109.31M
EBITDA -105.64M
EBIT -121.14M
Loss Per Share -0.29
Full Income Statement

Balance Sheet

The company has 166.12 million in cash and 23.34 million in debt, giving a net cash position of 142.77 million.

Cash & Cash Equivalents 166.12M
Total Debt 23.34M
Net Cash 142.77M
Net Cash Per Share n/a
Equity (Book Value) 340.63M
Book Value Per Share 0.89
Working Capital 310.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -74.33 million and capital expenditures -9.55 million, giving a free cash flow of -83.88 million.

Operating Cash Flow -74.33M
Capital Expenditures -9.55M
Free Cash Flow -83.88M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 48.25%, with operating and profit margins of -83.74% and -75.56%.

Gross Margin 48.25%
Operating Margin -83.74%
Pretax Margin -88.07%
Profit Margin -75.56%
EBITDA Margin -73.02%
EBIT Margin -83.74%
FCF Margin n/a

Dividends & Yields

FRA:FLB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -35.61%
Shareholder Yield -35.61%
Earnings Yield -23.27%
FCF Yield -17.86%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:FLB has an Altman Z-Score of -0.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.77
Piotroski F-Score 3